Form F-1 Scinai Immunotherapeutic
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/31/2026
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil settles lower on clues about Fed policy, rumors of Hormuz deal
- Dollar jumps after Warsh comments, set for weekly gain
- McKesson reports cybersecurity incident affecting its information systems
- Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- BioNTech ends colorectal cancer mRNA therapy trial early
- Needham sees mature node semiconductor strength in latest tracker
Scinai Immunotherapeutics (SCNI) files for 4.8M share offering by selling stockholders
September 22, 2025 10:50 AM EDTScinai Immunotherapeutics (NASDAQ: SCNI) has filed for up to 4,800,000 ADSs offering by selling stockholders. The ADSs represent 19,200,000,000 common shares,
... More